Sacral neuromodulation and botulinum toxin for overactive neurogenic bladder in children

被引:0
|
作者
Aubert, D. [1 ]
Galli, G. [1 ]
Ramella, B. [1 ]
Moro-Enemuwe, A. [1 ]
Fotso-Kamden, A. [1 ]
机构
[1] CHU St Jacques, Serv Chrurg Pediat, F-25000 Besancon, France
来源
PELVI-PERINEOLOGIE | 2007年 / 2卷 / 03期
关键词
paediatric urology; neurogenic bladder; sacral neuromodulation; botulinum toxin;
D O I
10.1007/s11608-007-0137-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Overactive bladder is a major cause of urinary tract damage in children with congenital neurogenic bladder. Anticholinergics and bladder augmentation are the standard treatments. S3 sacral neuromodulation (InterStim (R)) and botulinum toxin injection (Botox (R) 12 mg/kg or Dysport (R)) into the detrusor muscle have recently been shown to be effective in adults. In children, the use of these treatments is still uncommon but the first results are as promising as those in adults and no adverse effects have been reported. In France, there is a need for additionnal randomized, multicenter trials to confirm the benefits of these two procedures in paediatric urology.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 50 条
  • [21] Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder
    Lambregts, Annemarth P.
    Nieuwhof-Leppink, Anka J.
    Klijn, Aart J.
    Schroeder, Rogier P. J.
    JOURNAL OF PEDIATRIC UROLOGY, 2022, 18 (03) : 351.e1 - 351.e8
  • [22] Sacral neuromodulation for overactive bladder: Is it worth it?
    Hassouna, Magdy
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (5-6): : E454 - E454
  • [23] Sacral Neuromodulation for refractory overactive Bladder
    van Ophoven, Arndt
    UROLOGE, 2018, 57 (11): : 1375 - 1388
  • [24] Sacral neuromodulation for neurogenic bladder dysfunction
    Kessler, T. M.
    Woellner, J.
    Kozomara, M.
    Mordasini, L.
    Mehnert, U.
    UROLOGE, 2012, 51 (02): : 179 - 183
  • [25] SACRAL NEUROMODULATION IN CHILDREN AND YOUNG ADULTS FOR NEUROGENIC BLADDER DYSFUNCTION
    Jansen, Ilaria
    Marciano, Armando
    Mosiello, Giovanni
    Zaccara, Antonio
    Capitanucci, Maria Luisa
    Cannata', Vittorio
    Salsano, Maria Letizia
    Castelli, Enrico
    De Gennaro, Mario
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 : S15 - S15
  • [26] Intradetrusor botulinum toxin injections for neurogenic overactive bladder: Are we there yet?
    Lemack, Gary E.
    EUROPEAN UROLOGY, 2008, 53 (02) : 240 - 241
  • [27] Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2011, 186 (01): : 212 - 213
  • [28] Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
    Trinh, Hamilton
    Irish, Vicki
    Diaz, Mireya
    Atiemo, Humphrey
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2019, 23 (03) : 226 - 233
  • [29] Botulinum toxin and the overactive bladder
    Woodhouse, J. B.
    Patki, P.
    Shah, J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (09): : 460 - 464
  • [30] Mechanism and Priority of Botulinum Neurotoxin A versus Sacral Neuromodulation for Refractory Overactive Bladder: A Review
    Zhang, Yanping
    Ji, Fengping
    Liu, Erpeng
    Wen, Jian Guo
    UROLOGIA INTERNATIONALIS, 2021, 105 (11-12) : 929 - 934